What's Happening?
Prodeon Medical, a medical device company based in Sunnyvale, California, has received FDA 510(k) clearance for its Urocross Expander System. This novel, non-permanent implant is designed to treat lower urinary tract symptoms associated with benign prostatic
hyperplasia (BPH). The Urocross system remodels obstructing prostatic lobes during a six-month indwell period and is then retrieved, leaving no permanent foreign material. The clearance was supported by data from the Expander-1 Feasibility Trial and the Expander-2 Pivotal Trial, which involved 240 patients across the U.S. and Canada. The trials demonstrated significant improvements in urinary symptoms and quality of life, with no adverse effects on sexual function.
Why It's Important?
The FDA clearance of the Urocross Expander System marks a significant advancement in the treatment of BPH, a common condition affecting millions of aging men in the U.S. The system offers a minimally invasive alternative to traditional treatments that often involve permanent implants or tissue ablation. By avoiding permanent implants, the Urocross system preserves future treatment options and reduces potential long-term risks. This innovation could encourage earlier intervention in BPH management, potentially preventing irreversible bladder changes and improving patient outcomes. The system's ability to provide symptom relief while maintaining sexual function is particularly noteworthy, as it addresses a major concern for patients.
What's Next?
Prodeon Medical plans to initiate a controlled U.S. commercial release of the Urocross system later this year. The company aims to offer this technology as a first-line interventional therapy for BPH, even before medication. As the system becomes available, it is expected to influence clinical decision-making by providing a safe and effective treatment option that aligns with patient and surgeon preferences. The introduction of the Urocross system may also prompt further research and development in non-permanent, retrievable medical devices for other conditions.
